BUSINESSBLOOMBERG
Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Telix Pharma has upsized its convertible bond deal to $600 million. The article includes a photograph by Anthony Kwan for Bloomberg.
Telix Pharma has upsized its convertible bond deal to $600 million. The article includes a photograph by Anthony Kwan for Bloomberg.